New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2014
09:09 EDTKERXKeryx could benefit from House bill, says JMP Securities
After reviewing language in the House doc fix bill, JMP Securities indicates that reimbursement for Keryx's Zerenex drug may not be cut 37.5% beginning in 2016, as the firm had previously expected. The bill indicates that the reduction may be delayed until 2024, according t o the firm which keeps an Outperform rating on the shares.
News For KERX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
09:24 EDTKERXOn The Fly: Pre-market Movers
Subscribe for More Information
08:52 EDTKERXKeryx CFO to leave company by October
Keryx Biopharmaceuticals disclosed in a regulatory filing a planned consolidation of its finance and accounting function into its Boston office and that its CFO, James Oliviero, will be leaving Keryx by October. In connection with this transition, the company entered into an employment agreement with Oliviero that became effective on February 26 and will terminate on October 1, but may be extended upon the mutual agreement of the parties. The company has commenced a search for a new CFO who will be based in its Boston office. Oliviero will continue to manage the company’s finance and accounting team during the remainder of his tenure and will assist in the transition of his duties to the new CFO, Keryx said.
07:14 EDTKERXKeryx reports Q4 EPS (44c), consensus (37c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use